Cephalexin.
D000042:Absorption; D000818:Animals; D001082:Aqueous Humor; D001419:Bacteria / Q000187:drug effects; D001681:Biological Assay; D002415:Cats; D002511:Cephalosporins / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003967:Diarrhea / Q000139:chemically induced; D004285:Dogs; D003875:Drug Eruptions; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D000882:Haplorhini; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007668:Kidney / Q000378:metabolism; D051379:Mice; D010612:Pharyngitis / Q000188:drug therapy; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D011485:Protein Binding; D011537:Pruritus / Q000139:chemically induced; D011817:Rabbits; D051381:Rats; D012709:Serum Albumin; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D002511:Cephalosporins; D012709:Serum Albumin